T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Ciena
CIEN
$62.7B
| $53M | 0.01% |
2,788,245
+976,510
| +54% | +$18M |
|
|
EBSB
752
DELISTED
Meridian Bancorp, Inc.
EBSB
| $53M | 0.01% |
3,805,580
+105,910
| +3% | +$1.44M |
|
753
Myers Industries
MYE
$1.25B
| $52.7M | 0.01% |
4,097,148
+291,587
| +8% | +$3.44M |
|
754
Ligand Pharmaceuticals
LGND
$5.76B
| $52.6M | 0.01% |
786,958
+19,140
| +2% | +$1.16M |
|
|
FPO
755
DELISTED
First Potomac Realty Trust
FPO
| $52.5M | 0.01% |
5,798,402
+87,556
| +2% | +$806K |
|
|
VIVO
756
DELISTED
Meridian Bioscience Inc
VIVO
| $52.4M | 0.01% |
2,544,575
-38,580
| -1% | -$760K |
|
757
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $52.4M | 0.01% |
1,067,576
+291,999
| +38% | +$13.9M |
|
|
TESO
758
DELISTED
Tesco Corp
TESO
| $52M | 0.01% |
6,036,860
+501,250
| +9% | +$3.53M |
|
|
AGU
759
DELISTED
Agrium
AGU
| $52M | 0.01% |
588,540
-152,624
| -21% | -$13.2M |
|
760
Credicorp
BAP
$29.8B
| $51.8M | 0.01% |
395,459
+2,780
| +0.7% | +$306K |
|
761
Brady Corp
BRC
$4.43B
| $51.4M | 0.01% |
1,915,570
-3,560
| -0.2% | -$85.6K |
|
|
GPOR
762
DELISTED
Gulfport Energy Corp.
GPOR
| $51.3M | 0.01% |
1,810,278
+766,635
| +73% | +$20.2M |
|
763
CSX Corp
CSX
$92.9B
| $51.1M | 0.01% |
5,958,960
+147,954
| +3% | +$1.2M |
|
|
TNGO
764
DELISTED
Tangoe, Inc.
TNGO
| $51.1M | 0.01% |
6,481,590
-14,520
| -0.2% | -$114K |
|
765
Towne Bank
TOWN
$3.5B
| $50.9M | 0.01% |
2,651,191
+568,964
| +27% | +$10.5M |
|
766
Meritage Homes
MTH
$4.8B
| $50.8M | 0.01% |
2,787,080
-1,100,260
| -28% | -$17.5M |
|
767
Puma Biotechnology
PBYI
$450M
| $50.1M | 0.01% |
1,706,222
-13,390
| -0.8% | -$605K |
|
768
Dorman Products
DORM
$3.95B
| $49.9M | 0.01% |
916,660
-106,710
| -10% | -$5.07M |
|
|
FOLD
769
DELISTED
Amicus Therapeutics
FOLD
| $49.9M | 0.01% |
5,901,048
-28,020
| -0.5% | -$198K |
|
770
Snap-on
SNA
$20.9B
| $49.8M | 0.01% |
316,905
+76,435
| +32% | +$11.7M |
|
|
CPLA
771
DELISTED
Capella Education Company
CPLA
| $49.7M | 0.01% |
944,780
+47,670
| +5% | +$2.21M |
|
772
Domino's
DPZ
$11.6B
| $49.7M | 0.01% |
377,145
-8,980
| -2% | -$1.07M |
|
|
ESGR
773
DELISTED
Enstar Group
ESGR
| $49.6M | 0.01% |
305,282
-3,466
| -1% | -$536K |
|
774
Compañía de Minas Buenaventura
BVN
$8.55B
| $49.6M | 0.01% |
6,736,543
+1,662,905
| +33% | +$8.37M |
|
775
Moody's
MCO
$84.6B
| $49.5M | 0.01% |
512,616
+10,900
| +2% | +$980K |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.